MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration
Portugal · Lisbon · how to bid here →
Your path to submission
- Deadline: 14 October at 12:00 — 11 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: BUL, CES, DAN, DEU, ELL, ENG, SPA, EST, FIN, FRA, GLE, HRV, HUN, ITA, LIT, LAV, MLT, NLD, POL, POR, RON, SLK, SLV, SWE.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 3 months (19 awards, most recently November 2025) — by that rhythm the next award was due around January 2026. The last award went to NEW NET - RESEAU POUR LA FETE, LE POUVOIR D'AGIR ET LE BIEN ETRE.n = 19
- 23% of this buyer's awards went to companies that had already won here before (27 awards since 2024, spread over 21 companies). 77% went to new names.n = 27 awards since 2024
- The median procedure drew 4 bids (27 procedures with a bid count); 11% ended with a single bidder.n = 27
- 74% of awards went to companies from abroad (27 awards with a known winner country).n = 27
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 27/09/2026.
Foreign bidders
In Portugal, 2,503 contracts went to foreign companies over the last 3 years (of 2,046,191 recorded awards) — mostly from Spain, France, Germany.
Submission language: BUL.
Typical field: median 4 (from 19 awards).
What the buyer is looking for
Regulation (EU) 2023/1322, which makes the European Union Drugs Agency (EUDA), strengthens the Union’s preparedness for, and response to, drug-related health and security challenges. Article 15 in particular provides for a dedicated network of forensic and toxicology laboratories to enhance analytical capacity, harmonise methods, support quality assurance and facilitate the exchange of data and expertise across Member States. This strengthens and supports the recent detection, assessment and response to drug-related risks. Within this policy context, systematic investigation of drug metabolism is a cornerstone of clinical and forensic toxicology. Overall, the objective of this contract is to reinforce collective capacity across the EU to interpret toxicological findings and, critically, to improve the detection, identification, and timely reporting of exposure to NPS and other illicit…
Show full description
… drugs. By generating robust metabolic, pharmacological, and analytical data, and by consolidating these outputs into a prohibited, accessible EU database, the project aims to strengthen timely reporting, harmonise practices, and ensure that toxicological evidence can be translated more effectively into monitoring, early warning, and public health responses to emerging NPS threats.
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in Bulgarian, Czech, Danish, German, Greek, English, Spanish, Estonian, Finnish, French, Irish, Croatian, Hungarian, Italian, Lithuanian, Latvian, Maltese, Dutch, Polish, Portuguese, Romanian, Slovak, Slovenian, Swedish.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| HATEC ANONIMI ETAIRIA PLIROFORIKIS | 4 | 2024 |
| DOTSOFT OLOKLIROMENES EFARMOGES DIADIKTIOY KAI VASEON DEDOMENON AE | 4 | 2024 |
| UNIVERSITAT JAUME I DE CASTELLON | 1 | 2025 |
| On Site SL | 1 | 2025 |
| Adecco Recursos Humanos - Empresa de Trabalho Temporário, LDA. | 1 | 2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.